AYTU BIOPHARMA, INC Quarterly Other Assets, Noncurrent in USD from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Aytu Biopharma, Inc quarterly Other Assets, Noncurrent history and growth rate from Q2 2015 to Q2 2024.
  • Aytu Biopharma, Inc Other Assets, Noncurrent for the quarter ending June 30, 2024 was $2.23M, a 12.4% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.23M -$316K -12.4% Jun 30, 2024 10-K 2024-09-26
Q1 2024 $889K -$3K -0.34% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $907K +$86K +10.5% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $772K -$57K -6.88% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.55M +$1.78M +232% Jun 30, 2023 10-K 2024-09-26
Q1 2023 $892K +$118K +15.2% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $821K +$364K +79.7% Dec 31, 2022 10-Q 2023-02-21
Q3 2022 $829K +$364K +78.3% Sep 30, 2022 10-Q/A 2023-02-21
Q2 2022 $766K +$301K +64.7% Jun 30, 2022 10-K 2023-10-12
Q1 2022 $774K +$609K +369% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $457K Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $465K -$15.6M -97.1% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $465K +$432K +1309% Jun 30, 2021 10-K 2022-09-27
Q1 2021 $165K -$17M -99% Mar 31, 2021 10-Q 2021-05-17
Q3 2020 $16M -$2.28M -12.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $33K -$18.8M -99.8% Jun 30, 2020 10-K 2021-09-28
Q1 2020 $17.2M -$2.28M -11.7% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $17.7M -$2.28M -11.4% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 $18.3M +$7.62M +71.4% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $18.9M +$7.74M +69.6% Jun 30, 2019 10-K 2020-10-06
Q1 2019 $19.4M +$11.2M +136% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $20M +$11.4M +133% Dec 31, 2018 10-Q/A 2019-05-14
Q3 2018 $10.7M +$1.77M +19.9% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $11.1M +$1.89M +20.5% Jun 30, 2018 10-K 2019-09-26
Q1 2018 $8.24M -$1.32M -13.8% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $8.57M -$1.32M -13.3% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 $8.9M -$1.32M -12.9% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $9.23M -$1.32M -12.5% Jun 30, 2017 10-K 2018-09-06
Q1 2017 $9.56M Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $9.89M Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $10.2M Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $10.5M +$10.5M Jun 30, 2016 10-K 2017-08-31
Q2 2015 $0 Jun 30, 2015 10-K 2016-09-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.